angiotensin ii has been researched along with celastrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, RW; He, YP; Li, M; Liu, X; Si, CF; Wang, CY; Wang, M; Yang, Y; Zheng, QY | 1 |
| Chen, Q; Feng, SB; Hu, HY; Ni, B; Sun, C; Xu, XJ; Zhao, WB | 1 |
| Chen, T; Hu, X; Huang, W; Khan, ZA; Liang, G; Lin, K; Luo, W; Shan, P; Wang, J; Wang, S; Wu, G; Xuan, L; Ye, S | 1 |
3 other study(ies) available for angiotensin ii and celastrol
| Article | Year |
|---|---|
The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation.
Topics: Angiotensin II; Apoptosis; Cell Proliferation; Hep G2 Cells; Humans; Mitochondria; NADPH Oxidases; Nitric Oxide Synthase Type III; Pentacyclic Triterpenes; Reactive Oxygen Species; Signal Transduction; Triterpenes | 2016 |
Celastrol alleviates angiotensin II‑mediated vascular smooth muscle cell senescence via induction of autophagy.
Topics: Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Autophagy; Cell Cycle; Cellular Senescence; Gene Expression Regulation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes | 2017 |
Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3.
Topics: Angiotensin II; Animals; Cell Line; Drug Delivery Systems; HEK293 Cells; Humans; Mice; Myocytes, Cardiac; Pentacyclic Triterpenes; Protein Structure, Tertiary; Random Allocation; Rats; STAT3 Transcription Factor; Tripterygium; Triterpenes; Ventricular Remodeling | 2020 |